HTB

2007

Articles from New England Journal of Medicine

Volume 8 Number 3/4 March/April 2007 PDF

Volume 8 Number 1/2 January/February 2007

HIV’s siege of the mucosa establishes the systemic crisis of immune-hyperactivation and may have semi-permanent effects

Pharmacokinetic study of Triomune-40 in Malawi: higher d4T exposure suggests importance of using lower dose formulations of d4T

GSK stops development of brecanavir

FDA analysis of predicted responses to tipranavir/r

Important changes to US prescribing information for efavirenz

Changes to US product label for T-20 (enfuvirtide)

Wall Street Journal examines reason Abbott increased price of ritonavir

Access to treatment in the USA: waiting list for ARVs in South Carolina

Royalty-free license granted for development of tenofovir and topical microbicide

Novartis test case in India threatens the ARV pharmacy of the developing world

Thailand issues compulsory license to manufacture lopinavir/r: WHO criticised for challenging this essential access to treatment

Global Fund Board selects new executive director

Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV positive women

Hormonal contraception and the risk of HIV acquisition

Response to nevirapine containing HAART following single dose nevirapine for PMTCT

WHO paediatric recommendations

Masking the flavour of antiretrovirals in Thai children

Increased prevalence of cardiovascular disease among HIV-positive individuals coinfected with hepatitis C

Elevated risk of lung cancer among people with AIDS

Two phase III HIV microbicide trials stopped due to increased transmission

Presentations from satellite sessions at ICCAC

Full text articles online

TB coinfection

IAVI report: 2006 Year in Review

Volume 8 Number 1/2 January/February 2007 PDF

Post navigation